Advertisement

Topics

Encore Company Profile

16:39 EDT 22nd September 2017 | BioPortfolio

Based in Los Angeles, CA, Encore is a wholly-owned subsidiary of Navarre Corporation, and a leading retail software publisher. As a result of strategic licensing agreements, the company publishes a broad range of award-winning utility, entertainment, education and productivity software titles. Publishing brands include Hoyle, Marine Aquarium, Family Tree Maker, 3D Home Architect, Advantage, Wheel of Fortune and Jeopardy!; as well as the Riverdeep family of brands including The Print Shop, PrintMaster, Reader Rabbit and Mavis Beacon.


News Articles [48 Associated News Articles listed on BioPortfolio]

Dr. Reddy's Out-Licenses Plaque Psoriasis Drug to Encore Dermatology

NewsDr. Reddy's Laboratories announces the out-licensing of DFD-06 to Encore Dermatology. Under the terms of the agreement, Encore will be responsible for the commercialization of DFD-06 in the United...

Syndax Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Clinical and ...

Enrollment in all cohorts of ENCORE 601 have proceeded rapidly. The second stage of the ENCORE 601 cohort enrolling PD-1 (programmed death receptor-1) refractory melanoma Read more...

MIM Software Inc. Announces Updates to MIM Encore™

CLEVELAND, May 23, 2017 /PRNewswire/ -- MIM Software Inc. announced today significant updates to its MIM Encore solution. MIM Encore is a vendor-neutral application for viewing PET/CT, SPECT/...

emids Acquires Health IT Consulting Firm Encore Health Resources

emids, a growing global provider of IT services and solutions for the healthcare and life sciences industries, has acquired health IT consulting firm Encore Health Resources. For emids, the acquisitio...

SYNDROME de SJÖGREN : L'infection bactérienne qui augmente le risque - EULAR

Cette maladie rare dont on parle peu qui touche les glandes, puis les muqueuses, la peau, les articulations ou encore l'appareil respiratoire ne dispose pas encore de thérapie ciblée. Ce...

NOYADES : 1 parents sur 3 laisse son enfant sans surveillance à la piscine - C.S. Mott Poll

En France, l'Institut de Veille sanitaire recense chaque été environ 3 décès par jour d'enfants, de noyade accidentelle. Cette étude montre tous les progrès e...

Dr. Reddy's Laboratories Ltd. Announces The Out-Licensing Of DFD-06 To Encore Dermatology

  Life Sciences Jobs   ...

Syndax Pharmaceuticals Announces Advancement of ENCORE 601 in Non-Small Cell Lung Cancer Patients with Disease Progression on or After PD-1 Therapies

WALTHAM, Mass., May 16, 2017 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") (Nasdaq:SNDX), a clinical stage biopharmaceutical company focused on developing ent...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [17 Associated Clinical Trials listed on BioPortfolio]

3DKnee™ System vs. the MJS Knee System

The purpose of this study is to compare the survivorship and efficacy of the Encore 3DKnee™ system with that of the Encore MJS™ Knee System in a group of 600 patients for whom data col...

Retrospective Encore Reverse Shoulder Prosthesis Study

The purpose of this study is to evaluate the survivorship and efficacy of the Encore Reverse Shoulder Prosthesis in a group of no more than 50 subjects for whom data collection has already...

Efficacy of the CLP® Hip - Retrospective

The purpose of this study is to evaluate the survivorship and efficacy of the Encore CLP® Hip stem in a group of no more than 200 patients from whom data has already been collected.

Retrospective Study of the Linear™ Hip

The purpose of this study is to evaluate the use and efficacy of the Encore Linear™ Hip System in a group of 200 patients for whom data has already been collected.

Improving Negative Symptoms & Community Engagement in Veterans With Schizophrenia

The goal of this project is to evaluate an innovative psychosocial intervention package that will incorporate evidence-based treatment strategies to target the affective-motivational defic...

Companies [14 Associated Companies listed on BioPortfolio]

Encore, A Quintiles Company

Encore, A Quintiles Company, is an award-winning leader in health-information technology services and solutions. Founded in 2009 and led by Encore CEO Dana Sellers and President T...

Encore Health Resources

Encore Health Resources, founded by healthcare veterans Ivo Nelson and Dana Sellers, provides information technology consulting services to the provider segment of the healthcare ...

Encore Medical Technologies

Encore's trained technicians, some with over 25 years of renovation experience, use specialized equipment to create a superior product that looks and operates much like new equipment. From hospital be...

Encore Consumer Capital

Encore Consumer Capital is a San Francisco-based private equity investment firm focused on the consumer products industry. The firm has raised nearly $400 million in equity capita...

Encore Pharmaceuticals Inc.

Encore Pharmaceuticals Inc. (EncorePharma) is a drug discovery and development organization focused on early steps in streamlining the introduction of effective new products to the healthcare marketpl...

More Information about "Encore" on BioPortfolio

We have published hundreds of Encore news stories on BioPortfolio along with dozens of Encore Clinical Trials and PubMed Articles about Encore for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Encore Companies in our database. You can also find out about relevant Encore Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...


Corporate Database Quicklinks



Searches Linking to this Company Record